Lithium Ion

Lithium Ion

SCHEMBL2010293

[Al+3].[AlH4-].[H-].[H-].[H-].[Li+].[LiH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20969 0.78
Lithium Ion SCHEMBL424 0.78
Lithium Ion SCHEMBL27710560 0.78
Lithium Ion SCHEMBL6751753 0.78
Lithium Ion SCHEMBL9706864 0.78
Lithium Ion SCHEMBL3420827 0.78
Lithium Ion SCHEMBL2946829 0.78
Lithium Ion SCHEMBL13720140 0.78
Lithium Ion SCHEMBL3184815 0.67
Hydrochloric Acid SCHEMBL9689033 0.67 CYP3A4 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152530-A1 METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2011-06-23 US disclosed
WO-2011075602-A1 METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-06-23 WO disclosed